News
06-15-2011, 04:00 AM
QIAGEN N.V. has made an offer and entered into exclusive negotiations to purchase a 47% initial stake in Ipsogen S.A. and subsequently make a public offer to fully acquire a global leader in molecular profiling and personalized healthcare diagnostics for a broad range of hematological cancers.
More... (http://www.news-medical.net/news/20110615/QIAGEN-to-acquire-Ipsogen.aspx)
More... (http://www.news-medical.net/news/20110615/QIAGEN-to-acquire-Ipsogen.aspx)